• 19 SSO 014 Digital Banners MembershipBanner 1150x135 v5
  • 19 SSO 014 Digital Banners Landmark Series 1150x135 v5 1
  • ExpertEd Brand Refresh 1150x135 Surgonc Podcast Banner
  • SSO Mobile App Website Top 1150x135 Banner

ADVERTISEMENT

HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY

Weekly Update

Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.

Meta analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye Guided Sentinel Node Identification for Breast Cancer Surgery

Kedrzycki, M.S., Leiloglou, M., Ashrafian, H. et al.

https://doi.org/10.1245/s10434-020-09288-7

Citation: Kedrzycki, M.S., Leiloglou, M., Ashrafian, H. et al. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery. Ann Surg Oncol 28, 3738–3748 (2021).

Synopsis:  A meta-analysis of fluorescence guided sentinel node biopsy in breast cancer suggests non-inferiority to the gold standard radioisotope and blue dye approach. However, fluorescence imaging has many advantages as it is radiation free and does not lead to semi-permanent tattooing.

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study.

Voeten, D.M., van der Werf, L.R., Wilschut, J.A. et al.

https://doi.org/10.1245/s10434-020-09510-6

Citation: Voeten, D.M., van der Werf, L.R., Wilschut, J.A. et al. Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study. Ann Surg Oncol 28, 4484–4496 (2021).

Synopsis: A novel outcome measure for gastric cancer surgery is described. Failure to cure, defined as unsuccessful surgery, occurred in 22.3% of 3,862 patients ranging from 14.5%-34.8% among hospitals  with higher rates in hospitals with a low tendency to administer neoadjuvant chemotherapy.

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer

Listen to the ASO's new podcast, Speaking of SurgOnc®

Speaking of SurgOnc Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).

The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.

Listen to the podcast here.

ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.

Join the conversation! Follow the journal on Twitter and Facebook. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.

Scroll to Top